Bliss GVS Pharma Limited — Board Meeting, 29-07-2025: Outcome of Board Meeting
29-07-2025 | 06:10 pm
29-07-2025 | 06:10 pm
Bliss GVS Pharma has announced a board meeting where the key agenda item was the approval of its financial results for the latest quarter. The Board specifically greenlit the consolidated figures, offering retail investors a clear, comprehensive overview of the company's performance. This update is vital for assessing Bliss GVS Pharma's recent operational health.
No comments yet. Be the first to comment!
